Novavax (NVAX) Tumbles as JPMorgan Cuts Price Target by 80%, Downgrades to Underweight
Tweet Send to a Friend
Novavax (NASDAQ: NVAX) shares are down over 5% today after JPMorgan analyst Eric Joseph downgraded to Underweight from Neutral.The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE